FOCL

EDAP TMS S.A. - ADR

4.16

USD

+0.01

+0.24%

Sep 21, 09:38 UTC -4

Open

EDAP TMS S.A. - ADR Profile

About

FocalTherics develops, manufactures and markets minimally invasive medical devices to treat various conditions using proprietary focused ultrasound technology. The Company's flagship platform, Focal One Robotic HIFU, combines advanced imaging, real-time treatment planning, robotic precision and HIFU technology to deliver personalized focal therapy. FocalTherics, formerly known as EDAP TMS S.A., is based in AUSTIN, Texas.

Info & Links

CEO

Ryan Rhodes

Headquarters

Parc d�Activites la Poudrette-Lamartine 4/6, rue du Dauphin�
Vaulx-en-Velin69120 VAULX EN VELIN, I0 69120, FRANCE

Auditor

KPMG S.A.

Share holders

Employees

289

EDAP TMS S.A. - ADR Statistics

Valuation Measures

Market Capitalization²

196.42M

Enterprise Value

215.09M

Enterprise Value/EBITDA(ttm)

-8.51

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

2.25

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

46.05%

Operating Margin(ttm)

-48.13%

Profit Margin(ttm)

-57.02%

Return on Equity(ttm)

-248.00%

Return on Invested Capital(ttm)

-122.03%

Return on Assets(ttm)

-44.69%

Income Statement

Revenue(ttm)

77.77M

Revenue Per Share(ttm)

Gross Profit(ttm)

34.63M

EBITDA(ttm)³

-25.26M

Net Income Available to Common(ttm)

-38.97M

Diluted EPS(ttm)

-1.03

Share Statistics

Beta (5Y Monthly)

-0.07

52-Week Change

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

33.74M

% Held by Insiders

10.10%

% Held by Institutions

62.74%

Balance Sheet

Total Cash(mrq)

21.54M

Total Cash Per Share(mrq)

Total Debt(mrq)

40.21M

Total Debt/Equity(mrq)

-1246.95%

Current Ratio(mrq)

1.60%

Quick Ratio(mrq)

1.38%

Book Value Per Share(mrq)

-0.09

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.19

Free Cash Flow(ytd)

-8.66M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.